TP53 and obstructive sleep apnea syndrome: TP53 has also been implicated in canine OSA with whole genome sequencing and whole exome sequencing (WES) indicating frequent TP53 mutations in canine OSA tumors, at rates of up to 83%, specific mutation rates were variable between breeds (44, 84, 85).